US Stock MarketDetailed Quotes

IMNM Immunome

Watchlist
  • 8.850
  • -0.490-5.25%
Close Mar 10 16:00 ET
  • 8.550
  • -0.300-3.39%
Post 20:01 ET
723.68MMarket Cap-1.11P/E (TTM)

About Immunome Company

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.

Company Profile

SymbolIMNM
Company NameImmunome
Listing DateOct 2, 2020
Issue Price12.00
Founded2006
CEODr. Clay B. Siegall,PhD
MarketNASDAQ
Employees55
Fiscal Year Ends12-31
Address18702 North Creek Parkway,Suite 100
CityBothell
ProvinceWashington
CountryUnited States of America
Zip Code98011
Phone1-425-939-7410
Websitehttp://www.immunome.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Clay B. Siegall,PhD
  • Chief Executive Officer, President and Chairman of the Board
  • 14.87M
  • Bob Lechleider
  • Chief Medical Officer
  • 2.92M
  • Sandra G. Stoneman
  • Chief Legal Officer and General Counsel
  • --
  • Max Rosett
  • Principal Accounting Officer, Executive Vice President, Operations and Interim Chief Financial Officer
  • --
  • Kinney Horn
  • Chief Business Officer
  • --
  • Dr. Bruce Turner, M.D.,PhD
  • Chief Strategy Officer
  • --
  • Dr. Jack Higgins, PhD
  • Chief Scientific Officer
  • 1.84M
  • Philip Wagenheim
  • Director
  • 59.23K
  • Dr. Sandra M. Swain, M.D.
  • Director
  • --
  • Carol A. Schafer
  • Director
  • --
  • Jean-Jacques Bienaime
  • Independent Director
  • 287.93K
  • James P. Boylan, M.B.A.
  • Independent Director
  • 294.75K
  • Isaac Barchas, J.D.
  • Lead Independent Director
  • 296.59K

Trending Stocks

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
D.R. Horton
DHI
133.950
Lennar Corp
LEN
125.220
KB Home
KBH
63.980
4
Petroleo Brasileiro SA Petrobras
PBR
12.780
5
Ecopetrol
EC
9.740
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025